Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control

Ashley C. Parker, Jessica A. Jennings, Joel D. Bumgardner, Harry Courtney, Ernö Lindner, Warren O. Haggard

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Local versus systemic antibiotic delivery may be an effective strategy for treating musculoskeletal infections, especially when antibiotic-resistant bacteria are present. Lyophilized uncrosslinked, genipin crosslinked, and genipin crosslinked with poly(N-isopropylacrylamide) (PNIPAM) chitosan sponges were analyzed for their in vitro degradation rate, chemical crosslinking, antibiotic uptake, elution, biologic activity, and cytotoxicity. These evaluations were pursued to determine if crosslinking with genipin could be used to create a tailorable point of care loaded sponge for local infection control. Crosslinking the chitosan sponges decreased degradation in phosphate-buffered saline from 4.48 ± 2.28 wt % remaining of the uncrosslinked sponges to 78.82 ± 1.15 and 73.87 ± 1.27 wt % remaining at week 1 for the genipin and PNIPAM/genipin crosslinked sponges, respectively. The PNIPAM/genipin crosslinked sponges exhibited the most sustained release of biologically active antibiotics, with an average antibiotic release 63% higher than uncrosslinked and 37% higher than genipin crosslinked sponges, after 96 h. No significant cytotoxic effects from sponges or eluates were exhibited with NIH 3T3 fibroblasts. These preliminary results indicate that genipin crosslinked chitosan sponges, with or without PNIPAM, have potential as local delivery systems for adjunctive therapy for infection control, especially when longer degradation periods and higher antibiotic elutions are desired.

Original languageEnglish (US)
Pages (from-to)110-123
Number of pages14
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume101 B
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Chitosan
Antibiotics
Drug delivery
Anti-Bacterial Agents
Crosslinking
Degradation
Fibroblasts
Cytotoxicity
genipin
Bacteria
Phosphates
poly-N-isopropylacrylamide

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control. / Parker, Ashley C.; Jennings, Jessica A.; Bumgardner, Joel D.; Courtney, Harry; Lindner, Ernö; Haggard, Warren O.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 101 B, No. 1, 01.01.2013, p. 110-123.

Research output: Contribution to journalArticle

Parker, Ashley C. ; Jennings, Jessica A. ; Bumgardner, Joel D. ; Courtney, Harry ; Lindner, Ernö ; Haggard, Warren O. / Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control. In: Journal of Biomedical Materials Research - Part B Applied Biomaterials. 2013 ; Vol. 101 B, No. 1. pp. 110-123.
@article{db72364dd4ca49f8875deccd52fb98e6,
title = "Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control",
abstract = "Local versus systemic antibiotic delivery may be an effective strategy for treating musculoskeletal infections, especially when antibiotic-resistant bacteria are present. Lyophilized uncrosslinked, genipin crosslinked, and genipin crosslinked with poly(N-isopropylacrylamide) (PNIPAM) chitosan sponges were analyzed for their in vitro degradation rate, chemical crosslinking, antibiotic uptake, elution, biologic activity, and cytotoxicity. These evaluations were pursued to determine if crosslinking with genipin could be used to create a tailorable point of care loaded sponge for local infection control. Crosslinking the chitosan sponges decreased degradation in phosphate-buffered saline from 4.48 ± 2.28 wt {\%} remaining of the uncrosslinked sponges to 78.82 ± 1.15 and 73.87 ± 1.27 wt {\%} remaining at week 1 for the genipin and PNIPAM/genipin crosslinked sponges, respectively. The PNIPAM/genipin crosslinked sponges exhibited the most sustained release of biologically active antibiotics, with an average antibiotic release 63{\%} higher than uncrosslinked and 37{\%} higher than genipin crosslinked sponges, after 96 h. No significant cytotoxic effects from sponges or eluates were exhibited with NIH 3T3 fibroblasts. These preliminary results indicate that genipin crosslinked chitosan sponges, with or without PNIPAM, have potential as local delivery systems for adjunctive therapy for infection control, especially when longer degradation periods and higher antibiotic elutions are desired.",
author = "Parker, {Ashley C.} and Jennings, {Jessica A.} and Bumgardner, {Joel D.} and Harry Courtney and Ern{\"o} Lindner and Haggard, {Warren O.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1002/jbm.b.32822",
language = "English (US)",
volume = "101 B",
pages = "110--123",
journal = "Journal of Biomedical Materials Research",
issn = "1552-4973",
publisher = "Heterocorporation",
number = "1",

}

TY - JOUR

T1 - Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control

AU - Parker, Ashley C.

AU - Jennings, Jessica A.

AU - Bumgardner, Joel D.

AU - Courtney, Harry

AU - Lindner, Ernö

AU - Haggard, Warren O.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Local versus systemic antibiotic delivery may be an effective strategy for treating musculoskeletal infections, especially when antibiotic-resistant bacteria are present. Lyophilized uncrosslinked, genipin crosslinked, and genipin crosslinked with poly(N-isopropylacrylamide) (PNIPAM) chitosan sponges were analyzed for their in vitro degradation rate, chemical crosslinking, antibiotic uptake, elution, biologic activity, and cytotoxicity. These evaluations were pursued to determine if crosslinking with genipin could be used to create a tailorable point of care loaded sponge for local infection control. Crosslinking the chitosan sponges decreased degradation in phosphate-buffered saline from 4.48 ± 2.28 wt % remaining of the uncrosslinked sponges to 78.82 ± 1.15 and 73.87 ± 1.27 wt % remaining at week 1 for the genipin and PNIPAM/genipin crosslinked sponges, respectively. The PNIPAM/genipin crosslinked sponges exhibited the most sustained release of biologically active antibiotics, with an average antibiotic release 63% higher than uncrosslinked and 37% higher than genipin crosslinked sponges, after 96 h. No significant cytotoxic effects from sponges or eluates were exhibited with NIH 3T3 fibroblasts. These preliminary results indicate that genipin crosslinked chitosan sponges, with or without PNIPAM, have potential as local delivery systems for adjunctive therapy for infection control, especially when longer degradation periods and higher antibiotic elutions are desired.

AB - Local versus systemic antibiotic delivery may be an effective strategy for treating musculoskeletal infections, especially when antibiotic-resistant bacteria are present. Lyophilized uncrosslinked, genipin crosslinked, and genipin crosslinked with poly(N-isopropylacrylamide) (PNIPAM) chitosan sponges were analyzed for their in vitro degradation rate, chemical crosslinking, antibiotic uptake, elution, biologic activity, and cytotoxicity. These evaluations were pursued to determine if crosslinking with genipin could be used to create a tailorable point of care loaded sponge for local infection control. Crosslinking the chitosan sponges decreased degradation in phosphate-buffered saline from 4.48 ± 2.28 wt % remaining of the uncrosslinked sponges to 78.82 ± 1.15 and 73.87 ± 1.27 wt % remaining at week 1 for the genipin and PNIPAM/genipin crosslinked sponges, respectively. The PNIPAM/genipin crosslinked sponges exhibited the most sustained release of biologically active antibiotics, with an average antibiotic release 63% higher than uncrosslinked and 37% higher than genipin crosslinked sponges, after 96 h. No significant cytotoxic effects from sponges or eluates were exhibited with NIH 3T3 fibroblasts. These preliminary results indicate that genipin crosslinked chitosan sponges, with or without PNIPAM, have potential as local delivery systems for adjunctive therapy for infection control, especially when longer degradation periods and higher antibiotic elutions are desired.

UR - http://www.scopus.com/inward/record.url?scp=84871390607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871390607&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.32822

DO - 10.1002/jbm.b.32822

M3 - Article

VL - 101 B

SP - 110

EP - 123

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1552-4973

IS - 1

ER -